Diagnostic value of tumor markers for lung adenocarcinoma-associated malignant pleural effusion: a validation study and meta-analysis

Author:

Feng Mei,Zhu Jing,Liang Liqun,Zeng Ni,Wu Yanqiu,Wan Chun,Shen Yongchun,Wen Fuqiang

Funder

National Natural Science Foundation of China

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology,General Medicine,Surgery

Reference27 articles.

1. Agalioti T, Giannou AD, Stathopoulos GT (2015) Pleural involvement in lung cancer. J Thorac Dis 7:1021–1030

2. Thomas JM, Musani AI (2013) Malignant pleural effusions: a review. Clin Chest Med 34:459–471

3. Zugazagoitia J, Enguita AB, Nuñez JA et al (2014) The new IASLC/ATS/ERS lung adenocarcinoma classification from a clinical perspective: current concepts and future prospects. J Thorac Dis 6:S526–S536

4. Tang Y, He Z, Zhu Q et al (2014) The 2011 IASLC/ATS/ERS pulmonary adenocarcinoma classification: a landmark in personalized medicine for lung cancer management. J Thorac Dis 6:S589–S596

5. Kasapoglu US, Arınç S, Gungor S et al (2015) Prognostic factors affecting survival in non-small cell lung carcinoma patients with malignant pleural effusions. Clin Respir J. doi: 10.1111/crj.12292

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3